Threshold Pharmaceuticals, Inc (THLD): Opiniones

Eso eso parribaaaaaa

El 7.20 se esta atragantando!
Vamos jodiaaaaaa, arrea p'arriba !

Final a 7.20 (7.17 after hours). Vamos, vamos.

Mañana tiene que romper, sino, pabajo denuevorrrr

Threshold Pharmaceuticals, Inc. (THLD)

SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 05/30/12 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Chief Executive Officer of Threshold, is scheduled to present at the Jefferies 2012 Global Healthcare Conference on Wednesday, June 6, at 4:30 p.m. Eastern time in New York City.
A live webcast of the presentation will be available under Webcasts in the Investors section of www.thresholdpharm.com. A replay of the presentation will be archived on the site for 30 days.
About Threshold Pharmaceuticals
Threshold is a biotechnology company focused on the discovery and development of drugs targeting tumor hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, Threshold is building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs.www.thresholdpharm.com.
Contact:

Joel A. Fernandes

Threshold Pharmaceuticals, Inc.

650.474.8273

Email Contact

A Wall Street le gusta estas acciones!

Wall Street Loves These Stocks. Should You?

Esta niñuca nos va a alegrar la vida!!

Pedazo de muro que le han puesto en 7,20. no la dejan subir